Cyn3rgy Research Appreciates Your Patience Through the Covid-19 Pandemic
Amidst the COVID-19 pandemic, Cyn3rgy Research remains committed to your care and safety. When you come in for your scheduled study research visits, you will find that we have put in place additional protocols to further support your safety and the staff's safety at Cyn3rgy Research. Cyn3rgy staff will review the new safety protocols with you either via phone, prior to your visit, or at the scheduled time of your visit in our clinic. We encourage you to be compliant with the state-wide mask mandate. If you do not have a mask, we will provide one to you at your scheduled visit.

Currently enrolling participants for...

INFANT FORMULA
Infant Formula and Toddler Drink Feeding Intervention Through 24 Months of age.
Do you have a newborn who is exclusively formula-fed or exclusively human milk-fed?

Study visits and formula at no cost to you. Compensation for qualified participants up to $1,275 towards your time will be provided. 
LEARN MORE ​

ATOPIC DERMATITIS
Atopic Dermatitis is a chronic, recurring, inflammatory, and itchy skin condition that affects worldwide up to 25% of children and up to 12% of adults. Cyn3rgy Research is conducting a  
Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents aged 12 to 17, and adult men and women aged 18 years and older with Atopic Dermatitis.

LEARN MORE 

MENINGOCOCCAL
VACCINE STUDIES
Meningococcal Vaccines are routine vaccinations that are used to help prevent infection by Neisseria meningitidis bacteria. Cyn3rgy Research is conducting 3 Quadrivalent Meningococcal Conjugate Vaccine studies in healthy infants and toddlers.

LEARN MORE  

SINUSITIS
Sinusitis is an inflammation or swelling of the tissue lining the sinuses. Healthy sinuses are filled with air, however when they become blocked and filled with fluid, germs can grow and cause an infection. For Children,
things that can cause sinusitis include: Allergies, illness from
other kids at daycare or school, pacifiers, bottle drinking while lying on the back, and smoke in the environment. About 35 million Americans have Sinusitis at
least once each year. Contact Cyn3rgy Research to learn more about participating in this
​clinical trial.

LEARN MORE 

MEET THE TEAM

---

SELECT A STUDY YOU WOULD LIKE TO KNOW MORE ABOUT
• Infant Formula
• Atopic Dermatitis
• Meningococcal Disease
• Sinusitis

---

Watch our latest videos

Click to set custom HTML

Cyn3rgy Research and Development Staff

Acne Study

Cyn3rgy Investigational Flu Study

ARE YOU INTERESTED IN 
​PARTICIPATING IN A STUDY?
Complete the form. We will contact you when we are enrolling for a particular study that you might be qualified for.

Currently enrolling for...

Infant Formula
Infant Formula and Toddler Drink Feeding Intervention Through 24 Months of age. Do you have a newborn who is exclusively formula-fed or exclusively human milk-fed?

Study visits and formula at no cost to you. Compensation for qualified participants up to $1,275 towards your time will be provided. 

Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescent and Adult Subjects (Ages 2 Years and Older) with Mild to Moderate Atopic Dermatitis.

Meningococcal Vaccine Studies
Study 1: A Randomized Study to Describe the Safety of
an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers (Aged > 42 to < 89 days).

Sinusitis Study
2-12 years of age
​a study to determine the Efficacy of Antibiotics in
​Children with Acute Sinusitis.
​

​

Future Studies

​Amid the COVID-19 pandemic, Cyn3rgy Research is in communication with our Government and the Private Sector to collaborate on future Clinical Trial opportunities to test and potentially treat COVID-19. Thanks to our dedicated and highly skilled Cyn3rgy staff, we provide the safe, secure environment, training and infrastructure required
for these future Clinical Research Study opportunities. Please continue to check our website for updates on these future clinical trials,
​or contact us if you are interested in participating in future COVID-19 diagnostic or treatment studies.

---